Technical Analysis for LLY - Eli Lilly and Company

Grade Last Price % Change Price Change
grade C 113.19 1.62% 1.80
LLY closed up 1.62 percent on Friday, November 15, 2019, on 1.54 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Flat
See historical LLY trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Fell Below 20 DMA Bearish 1.62%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.62%
NR7 Range Contraction 0.35%
Overbought Stochastic Strength 0.35%
Stochastic Sell Signal Bearish 0.02%
Inside Day Range Contraction 0.02%
Overbought Stochastic Strength 0.02%
Spinning Top Other 0.35%

Older signals for LLY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Diabetes Pharmaceutical Products Neuroscience Schizophrenia Antibiotics Pulmonary Arterial Hypertension Psychiatry Animal Health Products Psychiatric Diagnosis Major Depressive Disorder Attention Deficit Hyperactivity Disorder Depression Wholesale Distributors Benign Prostatic Hyperplasia Obsessive Compulsive Disorder Osteoporosis Cardiovascular Products Bipolar Disorder Depressive Disorder Erectile Dysfunction Head And Neck Cancers Major Depressive Disorders Oncology Products Bulimia Nervosa High Cholesterol Psychology Respiratory And Other Diseases Testosterone Deficiency Treatment Resistant Depression
Is LLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 132.13
52 Week Low 101.36
Average Volume 3,156,895
200-Day Moving Average 115.754
50-Day Moving Average 110.8836
20-Day Moving Average 111.747
10-Day Moving Average 112.785
Average True Range 2.2022
ADX 9.94
+DI 23.5729
-DI 20.6715
Chandelier Exit (Long, 3 ATRs ) 108.0634
Chandelier Exit (Short, 3 ATRs ) 107.9666
Upper Bollinger Band 115.7361
Lower Bollinger Band 107.7579
Percent B (%b) 0.68
BandWidth 7.139521
MACD Line 0.7479
MACD Signal Line 0.725
MACD Histogram 0.0229
Fundamentals Value
Market Cap 119.41 Billion
Num Shares 1.05 Billion
EPS 2.31
Price-to-Earnings (P/E) Ratio 49.00
Price-to-Sales 4.03
Price-to-Book 6.30
PEG Ratio 1.77
Dividend 2.08
Dividend Yield 1.84%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 116.93
Resistance 3 (R3) 116.72 115.27 116.30
Resistance 2 (R2) 115.27 114.32 115.37 116.09
Resistance 1 (R1) 114.23 113.73 114.75 114.44 115.89
Pivot Point 112.78 112.78 113.04 112.88 112.78
Support 1 (S1) 111.74 111.83 112.26 111.95 110.49
Support 2 (S2) 110.29 111.24 110.39 110.29
Support 3 (S3) 109.25 110.29 110.08
Support 4 (S4) 109.46